Intarcia Therapeutics
Formerly BioMedicines, Intarcia Therapeutics is an American biopharmaceutical company developing therapies for diseases with long-term treatment requirements.
4
Funding Rounds
$479.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Co**** | - | - | linkedin facebook |
| Na*** Th******** | - | - | |
| Ku** Gr**** | - | - | - |
| Ja* S. Sk**** | - | - | - |
| Gi** Sa***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Intarcia Therapeutics has raised a total of $479.49m in funding over 4 rounds.
Key Insights:
- Intarcia Therapeutics series E funding round: $200m
- Intarcia Therapeutics , September 2016: $215m
- Intarcia Therapeutics funding round, May 2010: $14.49m
- Intarcia Therapeutics Series B round: $50m
Intarcia Therapeutics series E funding round
$200m
Intarcia Therapeutics , September 2016
$215m
Intarcia Therapeutics funding round, May 2010
$14.49m
Intarcia Therapeutics Series B round
$50m
Industries
Intarcia Therapeutics is active in the following industries:
- Pharmaceutical industry
- Healthcare
- Engineering
- Biomedical engineering
- Biopharmaceutical
- Technology
- Biology
- Biotechnology